AU8821901A - Stimulation of cellular regeneration and differentiation in the inner ear - Google Patents

Stimulation of cellular regeneration and differentiation in the inner ear

Info

Publication number
AU8821901A
AU8821901A AU8821901A AU8821901A AU8821901A AU 8821901 A AU8821901 A AU 8821901A AU 8821901 A AU8821901 A AU 8821901A AU 8821901 A AU8821901 A AU 8821901A AU 8821901 A AU8821901 A AU 8821901A
Authority
AU
Australia
Prior art keywords
differentiation
stimulation
inner ear
cellular regeneration
regeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU8821901A
Other languages
English (en)
Inventor
Jonathan Kil
Rendu Gu
Corinne Grigeur
Hubert Lowenheim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otogene AG
Otogene USA Inc
Original Assignee
Otogene AG
Otogene USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otogene AG, Otogene USA Inc filed Critical Otogene AG
Publication of AU8821901A publication Critical patent/AU8821901A/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/062—Sensory transducers, e.g. photoreceptors; Sensory neurons, e.g. for hearing, taste, smell, pH, touch, temperature, pain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU8821901A 2000-07-11 2001-07-10 Stimulation of cellular regeneration and differentiation in the inner ear Pending AU8821901A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61409900A 2000-07-11 2000-07-11
PCT/US2001/021793 WO2002004605A2 (en) 2000-07-11 2001-07-10 Stimulation of cellular regeneration and differentiation in the inner ear

Publications (1)

Publication Number Publication Date
AU8821901A true AU8821901A (en) 2002-01-21

Family

ID=24459860

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001288219A Ceased AU2001288219C1 (en) 2000-07-11 2001-07-10 Stimulation of cellular regeneration and differentiation in the inner ear
AU8821901A Pending AU8821901A (en) 2000-07-11 2001-07-10 Stimulation of cellular regeneration and differentiation in the inner ear

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001288219A Ceased AU2001288219C1 (en) 2000-07-11 2001-07-10 Stimulation of cellular regeneration and differentiation in the inner ear

Country Status (7)

Country Link
EP (1) EP1307542A2 (enExample)
JP (1) JP2004502785A (enExample)
KR (1) KR100896489B1 (enExample)
CN (1) CN1441841B (enExample)
AU (2) AU2001288219C1 (enExample)
CA (1) CA2412764C (enExample)
WO (1) WO2002004605A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7745209B2 (en) 2005-07-26 2010-06-29 Corning Incorporated Multilayered cell culture apparatus
AU2007334260A1 (en) 2006-11-15 2008-06-26 Massachusetts Eye & Ear Infirmary Generation of inner ear cells
EP2092052B1 (en) 2006-12-07 2020-09-23 Wilson Wolf Manufacturing Corporation Highly efficient gas permeable devices for culturing cells
DE102010007281A1 (de) 2010-02-08 2011-08-11 EMC microcollections GmbH, 72070 Neue Aminoalkyl-oxazol- und Aminoalkyl-thiazolcarbonsäureamide und ihre Anwendung zur Stimulation der endogenen situ Regeneration von Haarsinneszellen im Corti'schen Organ des Innenohres beim Säuger
US20150018404A1 (en) * 2011-08-03 2015-01-15 Quark Pharmaceuticals, Inc. Double-stranded oligonucleotide compounds for treating hearing and balance disorders
JP2016528161A (ja) 2012-01-12 2016-09-15 クォーク ファーマシューティカルズ インコーポレーティッドＱｕａｒｋ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． 聴覚およびバランス障害を治療するための併用療法
WO2014039781A1 (en) 2012-09-07 2014-03-13 Massachusetts Eye & Ear Infirmary Treating hearing loss
WO2017096233A1 (en) 2015-12-04 2017-06-08 Massachusetts Eye And Ear Infirmary Treatment of hearing loss by inhibition of casein kinase 1
WO2017132530A1 (en) * 2016-01-29 2017-08-03 Massachusetts Eye And Ear Infirmary Expansion and differentiation of inner ear supporting cells and methods of use thereof
CN114736924B (zh) * 2021-01-07 2024-11-22 中国科学院脑科学与智能技术卓越创新中心 异位联合过表达Atoh1和Ikzf2再生耳蜗外毛细胞及其应用
JP7760144B2 (ja) * 2021-04-21 2025-10-27 学校法人順天堂 内耳細胞の製造法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593290B1 (en) * 1996-11-01 2003-07-15 Genentech, Inc. Treatment of inner ear hair cells
DE19807426A1 (de) * 1998-02-23 1999-10-14 Otogene Biotechnologische Fors Verfahren zur Behandlung von Erkrankungen oder Störungen des Innenohrs
AU1223500A (en) * 1998-10-21 2000-05-08 Jonathan Kil Methods for stimulating the regeneration of inner ear cells

Also Published As

Publication number Publication date
CA2412764C (en) 2014-06-03
EP1307542A2 (en) 2003-05-07
AU2001288219B2 (en) 2006-11-23
CA2412764A1 (en) 2002-01-17
AU2001288219B9 (en) 2009-11-19
WO2002004605A3 (en) 2003-02-27
CN1441841B (zh) 2013-03-20
CN1441841A (zh) 2003-09-10
JP2004502785A (ja) 2004-01-29
KR100896489B1 (ko) 2009-05-08
WO2002004605A2 (en) 2002-01-17
KR20030046386A (ko) 2003-06-12
AU2001288219C1 (en) 2009-12-03

Similar Documents

Publication Publication Date Title
AU2002227300A1 (en) Reducing cellular damage in the human body
EP1408483A4 (en) POROUS SOUNDPROOF STRUCTURAL BODY AND METHOD FOR THE PRODUCTION THEREOF
EG23122A (en) Pyrrolcarboxamides and pyrrolcarbothioamides
EP1283702A4 (en) MEDICAL ASSOCIATION ARRANGEMENT AND METHOD OF THE APPLICATION
GB0111872D0 (en) Therapeutic agents and methods
AU2001233296A1 (en) Establishing and maintaining therapeutic hypothermia
PL368407A1 (en) Honeycomb structural body and method of manufacturing the structural body
AU9667901A (en) Mycoattractants and mycopesticides
EP1233728A4 (en) OPHTHALMIC DEVICE, METHOD FOR MANUFACTURING AND USE THEREOF
AU4468201A (en) External preparation for the skin and beautifying agents
PL373702A1 (en) Honeycomb structural body and assembly thereof
IL145904A0 (en) Functionally improved battery and method of making same
PL352330A1 (en) Derivatives of pyridopyranoazepine, making of same and use of same in therapy
EP1183030A4 (en) PROCESS FOR THE PREPARATION AND ITS USE OF N-DESMETHYLZOPICLONE
SG101527A1 (en) Filter construction, method of making, and method of use
GB9919764D0 (en) Thyristors and their manufacture
HUP0302054A3 (en) Polyacrylamide hydrogel and its use as an endoprosthesis
AU8821901A (en) Stimulation of cellular regeneration and differentiation in the inner ear
AU2001288219A1 (en) Stimulation of cellular regeneration and differentiation in the inner ear
PL352333A1 (en) Dihydrobenzodiazepines and use of same in treatment of dislipidemia
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
EP1181374A4 (en) NEW HUMAN AND MURINE KINASES
AU2001261375A1 (en) Human caspase-12 materials and methods
PL366606A1 (en) Absorbent article having improved fit and enhanced absorbent capacity and method for manufacturing this absorbent article
GB0014643D0 (en) Methods and assemblies